Effect of beclomethasone nasal spray on intraocular pressure in ocular hypertension or controlled glaucoma

Journal of Glaucoma

Volumn 22, Issue 2, 2013, Pages 84-87

  Yuen, Darana ^a   Buys, Yvonne M ^a   Jin, Ya Ping ^a,b   Alasbali, Tariq ^c   Trope, Graham E ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Glaucoma; Intraocular pressure; Nasal steroids; Ocular hypertension

Indexed keywords

BECLOMETASONE; PLACEBO; SODIUM CHLORIDE; GLUCOCORTICOID; NOSE SPRAY;

ADULT; ANTERIOR EYE SEGMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ACUITY; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; PHYSIOLOGY; PROSPECTIVE STUDY;

BECLOMETHASONE; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, OPEN-ANGLE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; NASAL SPRAYS; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; TONOMETRY, OCULAR; VISUAL ACUITY;

MLCS; MLOWN;

EID: 84879453991     PISSN: 10570829     EISSN: 1536481X     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3182254811     Document Type: Article

References (24)

1. Alfano JE. Changes in the intraocular pressure associated with systemic steroid therapy. Am J Ophthalmol. 1963;56: 245-247.
2. Bernstein HN, Schwartz B. Effects of long-term systemic steroids on ocular pressure and tonographic values. Arch Ophthalmol. 1962;68:742-753.
3. Bernstein HN, Mills DW, Becker B. Steroid-induced elevation of intraocular pressure. Arch Ophthalmol. 1963;70:15-18.
4. Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963;70:500-507.
5. Becker B, Mills DW. Elevated intraocular pressure following corticosteroid eye drops. JAMA. 1963;185:884-886.
6. Armaly MF. Effect of corticosteroids in intraocular pressure and fluid dynamics. I: the effect of dexamethasone in the normal eye. Arch Ophthalmol. 1963;70:482-491.
7. Armaly MF. Effect of corticosteroids in intraocular pressure and fluid dynamics. II: the effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol. 1963;70:492-499.
8. Buckley RJ. Allergic eye disease - a clinical challenge. Clin Exp Allergy. 1998;28:39-43.
9. Herschler J. Intractable intraocular hypertension induced by repository triamcinolone acetonide. Am J Ophthalmol. 1972;74: 501-504.
10. Kalina RE. Increased intraocular pressure following subconjunctival corticosteroid administration. Arch Ophthalmol. 1969; 81:788-790.
11. Aggarwal RK, Potamitis T, Chong NHV, et al. Extensive visual loss with topical facial steroids. Eye. 1993;7:664-666.
12. Tripathi RC, Parapuram SK, Tripathi BJ, et al. Corticosteroids and glaucoma risk. Drugs Aging. 1999;87:439-450.
13. Kersey JP, Broadway DC. Corticosteroid-induced glaucoma: a review of the literature. Eye. 2006;20:407-416.
14. Dykewicz MS, Fineman S. Executive summary of joint task force practice parameters on diagnosis and management of rhinitis. Ann Allergy Asthma Immunol. 1998;81:463-468.
15. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol. 2001;86:494-508.
16. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19:23-34.
17. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials. BMJ. 1998; 317:1624-1629.
18. Mabry RL. Corticosteroids in the management of upper respiratory allergy: the emerging role of steroid nasal sprays. Otolaryngol Head Neck Surg. 1992;107:855-860.
19. Prenner BM, Lanier BQ, Bernstein DI, et al. Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2010;125:1247-1253.
20. Micromedex Healthcare Series (database online). Greenwood Village, Colo: Thomson Reuters Healthcare Inc. Updated periodically.
21. Daley-Yates PT, Price AC, Sisson JR, et al. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol. 2001;5: 400-409.
22. Ozturk F, Yuceturk AV, Kurt E, et al. Evaluation of intraocular pressure and cataract formation following the long-term use of nasal corticosteroids. ENT J. 1998;77: 846-851.
23. Howland WC. Fluticasone proprionate: topical or systemic effects? Clin Exp Allergy. 1996;26:18-22.
24. Garbe E, LeLorier J, Boivin J, et al. Inhaled and nasal glucocorticosteroids and the risks of ocular hypertension or open-angle glaucoma. JAMA. 1997;277:722-727.